Morphine (MS Contin) and Ketamine Therapy | Tovani Health
MS Contin (Morphine) (also: Roxanol, Kadian) — Opioid analgesic (mu-receptor agonist)
Verdict at Tovani Health
Compatible with chronic-pain dosing; respiratory depression is what we monitor.
Morphine and ketamine are compatible. Standard opioid-sedation precautions apply. Patients on stable chronic-pain morphine for cancer or palliative care often benefit from ketamine without changing their opioid dose.
If you take MS Contin regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How MS Contin interacts with ketamine
Morphine is the prototypical mu-opioid agonist. Additive respiratory and CNS depression with ketamine matters most in the session window.
What we do at intake
Disclose dose, formulation (IR vs ER), and indication. We coordinate with your pain or palliative team.
Bottom line
Morphine and ketamine are compatible. Standard opioid-sedation precautions apply. Patients on stable chronic-pain morphine for cancer or palliative care often benefit from ketamine without changing their opioid dose.
Frequently Asked Questions
Will ketamine let me reduce my morphine dose?
For many chronic-pain patients, yes. Opioid-sparing is one of ketamine's documented uses.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on MS Contin (Morphine) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine as an adjuvant to opioids for cancer pain. Bell RF, Eccleston C, Kalso EA.. Cochrane Database of Systematic Reviews. 2017. PMID: 28657160
Cochrane systematic review evaluating ketamine added to opioid therapy for cancer pain.
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. Williams NR, Heifets BD, Blasey C, et al.. American Journal of Psychiatry. 2018. PMID: 30153752
Landmark study showing pretreatment with naltrexone (opioid receptor antagonist) blocks the antidepressant effect of ketamine.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.